🇺🇸 FDA
Patent

US 7569673

Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors

granted A61KA61K2039/505A61K51/1045

Quick answer

US patent 7569673 (Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
49
CPC classes
A61K, A61K2039/505, A61K51/1045, A61P, A61P35/00